HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Su-Jae Lee Selected Research

Selenium

1/2007Enhanced lung cancer cell killing by the combination of selenium and ionizing radiation.
10/2006p53-Mediated enhancement of radiosensitivity by selenophosphate synthetase 1 overexpression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Su-Jae Lee Research Topics

Disease

87Neoplasms (Cancer)
05/2022 - 08/2002
19Breast Neoplasms (Breast Cancer)
05/2022 - 01/2008
14Glioma (Gliomas)
01/2019 - 07/2007
11Lung Neoplasms (Lung Cancer)
01/2016 - 11/2006
11Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2012 - 07/2002
10Neoplasm Metastasis (Metastasis)
04/2022 - 01/2015
10Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2021 - 03/2006
9Carcinoma (Carcinomatosis)
04/2022 - 04/2006
9Carcinogenesis
01/2019 - 01/2004
8Glioblastoma (Glioblastoma Multiforme)
01/2022 - 02/2005
6Brain Neoplasms (Brain Tumor)
02/2018 - 02/2006
6Mitochondrial Diseases (Mitochondrial Disease)
10/2013 - 01/2007
5Hypoxia (Hypoxemia)
09/2021 - 07/2007
5Hepatocellular Carcinoma (Hepatoma)
01/2018 - 07/2009
4Colorectal Neoplasms (Colorectal Cancer)
04/2022 - 07/2019
3Colonic Neoplasms (Colon Cancer)
09/2019 - 12/2009
3Multiple Myeloma
02/2013 - 01/2007
2Melanoma (Melanoma, Malignant)
03/2020 - 01/2019
2Circulating Neoplastic Cells
02/2019 - 03/2018
2Laryngeal Neoplasms (Laryngeal Cancer)
11/2012 - 07/2010
2Leukemia
09/2011 - 01/2007
2T-Cell Lymphoma (Lymphoma, T Cell)
05/2008 - 02/2005
2Myeloid Leukemia (Leukemia, Myelocytic)
01/2007 - 08/2002
2Hematologic Neoplasms (Hematological Malignancy)
05/2005 - 08/2002
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2021
1Squamous Cell Carcinoma of Head and Neck
03/2021

Drug/Important Bio-Agent (IBA)

22Proteins (Proteins, Gene)FDA Link
04/2022 - 06/2006
10Arsenic Trioxide (Trisenox)FDA Link
01/2012 - 07/2002
9p38 Mitogen-Activated Protein KinasesIBA
01/2015 - 12/2003
9Reactive Oxygen Species (Oxygen Radicals)IBA
10/2013 - 12/2004
8Biological ProductsIBA
03/2020 - 02/2006
7MicroRNAs (MicroRNA)IBA
09/2021 - 06/2009
7Biomarkers (Surrogate Marker)IBA
09/2021 - 01/2010
6CaspasesIBA
01/2019 - 02/2003
6Cisplatin (Platino)FDA LinkGeneric
11/2018 - 02/2008
6phytosphingosineIBA
09/2017 - 02/2003
5Small Interfering RNA (siRNA)IBA
09/2019 - 12/2004
5SurvivinIBA
09/2019 - 11/2006
5Phosphotransferases (Kinase)IBA
11/2008 - 12/2003
5Sulindac (Copal)FDA LinkGeneric
09/2008 - 02/2005
4Transcription Factors (Transcription Factor)IBA
01/2020 - 06/2012
4CateninsIBA
01/2019 - 09/2012
4Peptides (Polypeptides)IBA
02/2018 - 07/2012
4Pharmaceutical PreparationsIBA
01/2016 - 02/2005
4Paclitaxel (Taxol)FDA LinkGeneric
08/2015 - 09/2011
4Cytochromes c (Cytochrome c)IBA
10/2013 - 02/2003
3Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
04/2022 - 10/2017
3Epidermal Growth Factor (EGF)IBA
01/2020 - 03/2012
3Poly (ADP-Ribose) Polymerase-1IBA
01/2019 - 12/2004
3Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2018 - 10/2006
3Protein Kinases (Protein Kinase)IBA
09/2017 - 03/2006
3AgarIBA
02/2016 - 04/2011
3TriterpenesIBA
10/2015 - 10/2009
3Etoposide (VP 16)FDA LinkGeneric
08/2015 - 11/2010
3Mitogen-Activated Protein KinasesIBA
09/2014 - 12/2003
32-pyroneIBA
08/2013 - 01/2012
35- bromo- 3- (3- hydroxyprop- 1- ynyl)- 2H- pyran- 2- oneIBA
08/2013 - 01/2012
3Aligeron (AS 2)IBA
01/2012 - 12/2004
3Glucose (Dextrose)FDA LinkGeneric
10/2011 - 05/2007
3VorinostatFDA Link
12/2009 - 03/2008
3NF-kappa B (NF-kB)IBA
01/2008 - 11/2004
2Therapeutic UsesIBA
04/2022 - 02/2005
2Oxygen (Dioxygen)IBA
11/2021 - 01/2019
2Ligases (Synthetase)IBA
11/2021 - 04/2010
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
09/2021 - 03/2012
2VimentinIBA
03/2021 - 06/2016
2STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
09/2019 - 01/2018
2Hyaluronic Acid (Hyaluronan)IBA
07/2019 - 01/2017
2CytokinesIBA
06/2019 - 02/2016
2GoldIBA
01/2019 - 01/2017
2AMP-Activated Protein KinasesIBA
11/2018 - 02/2008
2src-Family KinasesIBA
01/2018 - 01/2015
2LigandsIBA
01/2018 - 07/2009
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2018 - 11/2010
2PhloroglucinolIBA
08/2015 - 01/2015
2Antineoplastic Agents (Antineoplastics)IBA
01/2015 - 01/2007
2Hypoxia-Inducible Factor 1IBA
11/2014 - 07/2007
2SuspensionsIBA
12/2013 - 06/2011
2NestinIBA
12/2013 - 11/2010
2Nitric Oxide (Nitrogen Monoxide)FDA Link
09/2013 - 02/2006
2cobaltous chloride (cobalt(II)chloride)IBA
11/2012 - 07/2007
2celastrol methyl esterIBA
09/2011 - 10/2009
2Phosphatidylinositols (Phosphatidylinositol)IBA
07/2011 - 02/2005
2ClaudinsIBA
05/2011 - 01/2010
2Claudin-1IBA
05/2011 - 01/2010
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2008 - 01/2007
2Caspase 8 (Caspase-8)IBA
01/2007 - 02/2003
2SeleniumIBA
01/2007 - 10/2006
2Penicillamine (Cuprimine)FDA Link
02/2006 - 05/2003
2DNA (Deoxyribonucleic Acid)IBA
02/2006 - 01/2004
1Estrogen Receptor Modulators (Antiestrogen)IBA
05/2022
1Aromatase InhibitorsIBA
05/2022
1AntibodiesIBA
04/2022
1Leucine-Rich Repeat ProteinsIBA
11/2021
1Insulin-Like Growth Factor Binding Protein 3IBA
03/2021

Therapy/Procedure

21Radiotherapy
12/2021 - 02/2005
19Therapeutics
05/2022 - 05/2003
6Drug Therapy (Chemotherapy)
12/2021 - 07/2007
3Aftercare (After-Treatment)
09/2013 - 11/2010
2Molecular Targeted Therapy
01/2016 - 01/2016